Document:

Promissory Note

 Exhibit 10.2 
  
 

 
  
 Lee P. Brennan 
 Vice President 
 Corporate Banking Credit 
  
 February 27, 2006 
  
 CDI Corp. 
 1717 Arch Street 35th Floor

 Philadelphia, PA 19103 
 Attention: Scott J. Salantrie

  
 Dear Scott: 
  
 This letter supersedes and replaces our advice of line of credit letter dated October 25, 2005. 
  
 We are pleased to advise you that based upon your annual financial statements for the fiscal
year 2004, and your filings of interim information contained in your 10-Q dated as of September 30, 2005 JPMorgan Chase Bank (the “Bank”) has approved your request for a line of credit in the aggregate amount of $35,000,000.00. Our
officers may, at their discretion, make short term loans to CDI Corporation, on such terms as are mutually agreed upon between us from time to time. 
  
 Borrowings under this line are intended to be used to meet your normal short term capital needs and will bear interest at such a rate as shall be mutually agreed upon by
each of us from time to time. 
  
 As this line is not a commitment, credit
availability is, in addition, subject to your execution and delivery of such documentation as the Bank deems appropriate and the receipt and continuing satisfaction with current financial information (including without limitation audited annual and
unaudited quarterly financial statements, promptly prepared and received), which information will be furnished to the Bank as it may from time to time reasonably request, and continuing satisfaction with your financial condition, business affairs
and prospects. This line expires on June 30, 2006. 
  
 We are pleased to be of
service and trust you will call upon us to assist in any of your banking requirements. 
  
 Very truly yours, 
  
 /s/ Lee P. Brennan 
  
 JPMorgan Chase Bank, N.A. • Commercial Banking • NY1-L332,
277 Park Avenue, 16th Floor, New York, NY 10172 
  
 Telephone: 212
622 3623 • Facsimile: 646 534 3078 
 lee.brennan@chase.com 

 February 27, 2006 
  

ENDORSEMENT NO. 2 
  
 The Promissory Note dated November 16, 2004 (the “Note”) of CDI CORP. (the “Borrower”) as amended by Endorsement 1 to which
this Endorsement No. 2 is attached and evidencing a $25,000,000 uncommitted line of credit facility (“Line of Credit”) extended by JPMORGAN CHASE BANK, N.A., formerly JPMorganChase Bank (the “Bank”) to the Borrower is
hereby amended by: 
  

	 	1.	deleting “$25,000,000” from the caption and in the first paragraph of the Note, and substituting therefor “$35,000,000” as the amended principal amount of the
Note and available amount under the Line of Credit; 

  

	 	2.	deleting “February 28, 2006” in the first paragraph of the Note and substituting therefore “June 30, 2006” as the amended Maturity Date of the Note and
expiration date for the Line of Credit. 

  

			
	CDI CORP.
		
	By:	 	 /s/ Mark A.
Kerschner                            2/28/06

	Title:	 	CFO
	
	JPMORGAN CHASE BANK, N.A.
		
	By:	 	 /s/ Lee P. Brennan

	 	 	Vice PresidentPromissory Note

 Exhibit 10.3 
  
 CHASE [Logo] 
  
 Lee P .Brennan 
 Vice President

 Corporate Banking Credit 
  
 October 25, 2005 
  
 Mr. Scott J. Salantrie 
 CDI Corp. 
 1717 Arch Street, 35th Floor 
 Philadelphia, P A 19103 
  
 Dear Scott: 
  
 This letter supersedes and replaces our advice of line of credit letter dated November 16, 2004. 
  
 We are pleased to advise you that based upon your annual financial statements for the fiscal
year 2004, JPMorgan Chase Bank (the “Bank”) has approved your request for a line of credit in the aggregate amount of $25,000,000.00. Our officers may, at their discretion, make short term loans to CDI Corporation on such terms as are
mutually agreed upon between us from time to time. 
  
 Borrowings under this line
are intended to be used to meet your normal short term capital needs and will bear interest at such a rate as shall be mutually agreed upon by each of us from time to time. 
  
 As this line is not a commitment, credit availability is, in addition, subject to your execution and delivery of such documentation as the
Bank deems appropriate and the receipt and continuing satisfaction with current financial information (including without limitation audited annual and unaudited quarterly financial statements, promptly prepared and received), which information will
be furnished to the Bank as it may from time to time reasonably request, and continuing satisfaction with your financial condition, business affairs and prospects. This line expires on February 28, 2006. 
  
 We are pleased to be of service and trust you will call upon
us to assist in any of your banking requirements. 
  
 Very truly yours, 
  
 /s/ Lee P. Brennan

 Lee P. Brennan 
 Vice President 
  
 JPMorgan Chase Bank, N.A.· Commercial Banking· NY1-L332, 277 Park Avenue, 16th Floor, New York, NY 10172 
 Telephone: 2126223623 • Facsimile: 646 534 3078 
 lee.brennan@chase.com 

 October 25, 2005 
  
 ENDORSEMENT NO.1 
  
 The Promissory Note dated November 16, 2004 (the “Note”) of CDI CORP. (the “Borrower”) to which this Endorsement
No. 1 is attached and evidencing a $20,000,000 uncommitted line of credit facility (“Line of Credit”) extended by JPMORGAN CHASE BANK, N.A., formerly JPMorgan Chase Bank (the “Bank”) to the Borrower is hereby amended
by: 
  

	 	1.	deleting “$20,000,000” from the caption and in the first paragraph of the Note, and substituting therefor “$25,000,000” as the amended principal amount of the
Note and available amount under the Line of Credit; 

  

	 	2.	deleting “November 15, 2005” in the first paragraph of the Note and substituting therefor “February 28, 2006” as the amended Maturity Date of the Note and
expiration date for the Line of Credit. 

  

			
	CDI CORP.
		
	By:	 	 /s/ Mark A. Kerschner

	Title:	 	EVP
	
	JPMORGAN CHASE BANK, N.A.
		
	By:	 	 /s/ Lee P. Brennan

	 	 	Vice PresidentNon-Employee Director Compensation Arrangements

 Exhibit 10.23 
 Non-Employee Director Compensation Arrangements 
 Effective July 2003, each non-employee director receives an annual
retainer of $20,000 and a fee of $1,500 for each Board of Directors meeting attended ($750 for attendance by telephone). For their services as members of the Audit, Compensation, and Corporate Governance and Nominating Committees, non-employee
directors are paid an annual retainer of $5,000 and a fee of $1,000 for each meeting attended (plus $500 for serving as a committee chairman). Effective July 2005, for their services as members of the Strategic Advisory Committee, non-employee
directors are paid a fee of $2,000 for each meeting attended, and the committee chairman is paid an annual retainer of $25,000, but is not paid any fee for meetings attended. In the event that a board meeting and a board committee meeting, other
than a Strategic Advisory Committee meeting, fall on the same day, non-employee directors receive a fee for attending the board meeting only. Effective January 2006, the lead independent director receives an annual retainer of $5,000. Non-employee
directors are also eligible for reimbursement of expenses incurred in connection with attending board and committee meetings. 
 Non-employee directors are
entitled to participate in the Company’s 2000 Non-Employee Directors’ Stock Option Plan (the “Directors’ Plan”). The Directors’ Plan was adopted by the Company’s Board of Directors in March 2000 and approved by the
Company’s stockholders in August 2000, and was effective upon the closing of the Company’s initial public offering. The Directors’ Plan has a term of ten years, unless terminated sooner by the Company’s Board of Directors. As of
March 15, 2006, a total of 500,000 shares of the Company’s common stock have been reserved for issuance under the Directors’ Plan. In May 2002, the Company’s stockholders approved proposed amendments to the Directors’ Plan
to increase the number of options that may be granted to each non-employee director and to adjust the date of grant and the term over which shares vest. Under the Directors’ Plan, each non-employee director who becomes a director of the Company
will be automatically granted on the date on which such person first becomes a director, a non-statutory stock option to purchase 20,000 shares of common stock that vests over four years. Beginning with the 2002 Annual Stockholders Meeting and each
year thereafter, each non-employee director will automatically be granted, one day following each year’s annual meeting of stockholders, a non-statutory option to purchase 5,000 shares of common stock that will vest one day before the annual
meeting of stockholders subsequent to the date of grant. In addition, the Directors’ Plan provides for automatic and non-discretionary annual option grants to certain non-employee directors who serve on certain committees of the Board as
follows: 1,000 shares of common stock for services as a member of the Audit and/or Compensation and/or Corporate Governance and Nominating Committees or 2,000 shares of common stock for services as the Chairman of any such committee. On May 26,
2005, the Company granted an option to purchase 5,000 shares of common stock to each non-employee director. In addition, the Company granted an option to purchase 2,000 shares of common stock to each of Dr. Deleage, Dr. Davis and
Dr. Walsh for their services as the Chairman of the Company’s Audit, Compensation and Corporate Governance and Nominating Committee, respectively. For their services as members of the Audit Committee, the Company granted an option to
purchase 1,000 shares of common stock to each of Dr. Davis and Dr. Homcy. For their services as members of the Compensation Committee, we granted an option to purchase 1,000 shares of common stock to each of Dr. Deleage and
Dr. Walsh. For their services as members of the Corporate Governance and Nominating Committee, we granted an option to purchase 1,000 shares of common stock to each of Dr. Chabner, Dr. Davis and Dr. Deleage. In 2005, options
granted to Drs. Chabner, Davis, Deleage, Homcy, Khosla and Walsh under the Directors’ Plan were granted at an exercise price of $4.55, the fair market value of the stock subject to the option at the date of grant. As of March 15, 2005, no
options had been exercised under the Directors’ Plan.

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00099-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00099-of-00352.parquet"}], [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00099-of-00352.parquet"}]]